Endothelial Alpha1-adrenoceptors Regulate Neo-angiogenesis

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2007 Dec 18

PMID 18084315

Citations 40

Authors

M Ciccarelli

G Santulli

A Campanile

G Galasso

P Cervero

G G Altobelli

V Cimini

L Pastore

F Piscione

B Trimarco

G Iaccarino

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Intact endothelium plays a pivotal role in post-ischaemic angiogenesis. It is a phenomenon finely tuned by activation and inhibition of several endothelial receptors. The presence of alpha(1)-adrenoceptors on the endothelium suggests that these receptors may participate in regenerative phenomena by regulating the responses of endothelial cells involved in neo-angiogenesis.

Experimental Approach: We evaluated the expression of the subtypes of the alpha(1)-adrenoceptor in isolated endothelial cells harvested from Wistar-Kyoto (WKY) rats. We explored the possibility these alpha(1)-adrenoceptors may influence the pro-angiogenic phenotype of endothelial cells in vitro. In vivo, we used a model of hindlimb ischaemia in WKY rats, to assess the effects of alpha(1) adrenoceptor agonist or antagonist on angiogenesis in the ischaemic hindlimb by laser Doppler blood flow measurements, digital angiographies, hindlimb perfusion with dyed beads and histological evaluation.

Key Results: In vitro, pharmacological antagonism of alpha(1)-adrenoceptors in endothelial cells from WKY rats by doxazosin enhanced, while stimulation of these adrenoceptors with phenylephrine, inhibited endothelial cell proliferation and DNA synthesis, ERK and retinoblastoma protein (Rb) phosphorylation, cell migration and tubule formation. In vivo, we found increased alpha(1)-adrenoceptor density in the ischaemic hindlimb, compared to non-ischaemic hindlimb, suggesting an enhanced alpha(1)-adrenoceptor tone in the ischaemic tissue. Treatment with doxazosin (0.06 mg kg(-1) day(-1) for 14 days) did not alter systemic blood pressure but enhanced neo-angiogenesis in the ischaemic hindlimb, as measured by all our assays.

Conclusions: Our findings support the hypothesis that the alpha(1)-adrenoceptors in endothelial cells provide a negative regulation of angiogenesis.

Citing Articles

HOXD9 regulated mitophagy to promote endothelial progenitor cells angiogenesis and deep vein thrombosis recanalization and resolution.

Xiujin Z, Lili G, Jing F, Wenhai Y, Sikai L, Wan-Yin S Mol Med. 2024; 30(1):84.

PMID: 38867168 PMC: 11167931. DOI: 10.1186/s10020-024-00852-5.

Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines.

Priyanka H, Pratap U, Nair R, Vasantharekha R, ThyagaRajan S Med Oncol. 2024; 41(5):92.

PMID: 38526769 DOI: 10.1007/s12032-024-02322-8.

Adrenoceptors in the Eye - Physiological and Pathophysiological Relevance.

Ruan Y, Buonfiglio F, Gericke A Handb Exp Pharmacol. 2023; 285:453-505.

PMID: 38082203 DOI: 10.1007/164_2023_702.

COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells.

Jankauskas S, Kansakar U, Sardu C, Varzideh F, Avvisato R, Wang X Antioxidants (Basel). 2023; 12(2).

PMID: 36829885 PMC: 9952002. DOI: 10.3390/antiox12020326.

Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.

Magdy Beshbishy A, Oti V, Hussein D, Rehan I, Adeyemi O, Rivero-Perez N Front Public Health. 2021; 9:591982.

PMID: 34307267 PMC: 8292635. DOI: 10.3389/fpubh.2021.591982.

References

Morisco C, Marrone C, Trimarco V, Crispo S, Monti M, Sadoshima J . Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression. Cardiovasc Res. 2007; 76(3):453-64. DOI: 10.1016/j.cardiores.2007.07.012. View

Lanni F, Santulli G, Izzo R, Rubattu S, Zanda B, Volpe M . The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens. 2007; 25(3):551-6. DOI: 10.1097/HJH.0b013e328013cd67. View

Iaccarino G, Keys J, Rapacciuolo A, Shotwell K, Lefkowitz R, Rockman H . Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors. J Am Coll Cardiol. 2001; 38(2):534-40. DOI: 10.1016/s0735-1097(01)01396-1. View

Kanda S, Miyata Y, Kanetake H . Role of focal adhesion formation in migration and morphogenesis of endothelial cells. Cell Signal. 2004; 16(11):1273-81. DOI: 10.1016/j.cellsig.2004.03.010. View

Lee E, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P . Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest. 2003; 111(12):1853-62. PMC: 161419. DOI: 10.1172/JCI16929. View

Alexandrov A, Keffel S, Goepel M, Michel M . Stimulation of alpha1A-adrenoceptors in Rat-1 cells inhibits extracellular signal-regulated kinase by activating p38 mitogen-activated protein kinase. Mol Pharmacol. 1998; 54(5):755-60. DOI: 10.1124/mol.54.5.755. View

Guimaraes S, Moura D . Vascular adrenoceptors: an update. Pharmacol Rev. 2001; 53(2):319-56. View

Fulgenzi G, Graciotti L, Collis M, Hudlicka O . The effect of alpha 1 adrenoceptor antagonist prazosin on capillary supply, blood flow and performance in a rat model of chronic muscle ischaemia. Eur J Vasc Endovasc Surg. 1998; 16(1):71-7. DOI: 10.1016/s1078-5884(98)80095-6. View

Hudlicka O . Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation?. Microcirculation. 1998; 5(1):7-23. View

10.

McKee A, Van Riper D, Davison C, Singer H . Gender-dependent modulation of alpha 1-adrenergic responses in rat mesenteric arteries. Am J Physiol Heart Circ Physiol. 2003; 284(5):H1737-43. DOI: 10.1152/ajpheart.00779.2002. View

11.

Tuttle J, Falcone J . Nitric oxide release during alpha1-adrenoceptor-mediated constriction of arterioles. Am J Physiol Heart Circ Physiol. 2001; 281(2):H873-81. DOI: 10.1152/ajpheart.2001.281.2.H873. View

12.

Gibson C, Cannon C, Daley W, Dodge Jr J, Alexander Jr B, MARBLE S . TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996; 93(5):879-88. DOI: 10.1161/01.cir.93.5.879. View

13.

Carmeliet P . Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000; 6(4):389-95. DOI: 10.1038/74651. View

14.

Emanueli C, Salis M, Stacca T, Gaspa L, Chao J, Chao L . Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer. Hypertension. 2001; 38(1):136-41. DOI: 10.1161/01.hyp.38.1.136. View

15.

Iaccarino G, Smithwick L, Lefkowitz R, Koch W . Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis. Proc Natl Acad Sci U S A. 1999; 96(7):3945-50. PMC: 22400. DOI: 10.1073/pnas.96.7.3945. View

16.

Iaccarino G, Tomhave E, Lefkowitz R, Koch W . Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation. 1998; 98(17):1783-9. DOI: 10.1161/01.cir.98.17.1783. View

17.

Gong H, Sun H, Koch W, Rau T, Eschenhagen T, Ravens U . Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation. 2002; 105(21):2497-503. DOI: 10.1161/01.cir.0000017187.61348.95. View

18.

Cooke J, Losordo D . Nitric oxide and angiogenesis. Circulation. 2002; 105(18):2133-5. DOI: 10.1161/01.cir.0000014928.45119.73. View

19.

Akhter S, Luttrell L, Rockman H, Iaccarino G, Lefkowitz R, Koch W . Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998; 280(5363):574-7. DOI: 10.1126/science.280.5363.574. View

20.

Deshpande A, Sicinski P, Hinds P . Cyclins and cdks in development and cancer: a perspective. Oncogene. 2005; 24(17):2909-15. DOI: 10.1038/sj.onc.1208618. View